1. |
Schuster M, Engelhardt L, Erler W, et al. Levobupivacaine vs. pivacaine for continuous femoral anal gesia after anterior cruciate ligament reconstruction[J]. Schmerz, 2011, 25(1):62-68.
|
2. |
Higgins LD, Taylor MK, Park DA, et al. Reliability and validity of the International Knee Documentation Committee (IKDC) Subjective Knee Form[J]. Joint Bone Spine, 2007, 74(6):594-599.
|
3. |
Noonan B, Chung KS. A practical review of the mechanisms of pain and pain management following ACL reconstruction[J]. Orthopedics, 2006, 29(11):999-1005.
|
4. |
Wulf H, Loewe J, Gnutzmann KH, et al. Femoral nerve block with ropivacaine or bupivacaine in day case anterior crucial ligament reconstruction[J]. Acta Anaesthesiol Scand, 2010, 54(4):414-420.
|
5. |
Viscusi ER, Parvizi J, Tarity TD. Developments in spinal and epidural anesthesia and nerve blocks for total joint arthroplasty:what is new and exciting in pain management[J]. Instr Course Lect, 2007, 56:139-145.
|
6. |
Coda BA, Hill HF, Hunt EB, et al. Cognitive and motor function impairments during continuous opioid analgesic infusions[J]. Hum Psychopharmacol, 1993, 8(8):383-400.
|
7. |
Kimmel SE, Berlin JA, Reilly M, et al. Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction[J]. Ann Intern Med, 2005, 142(3):157-164.
|
8. |
Brophy JM. Celecoxib and cardiovascular risks[J]. Expert Opin Drag Saf, 2005, 4(6):1005-1015..
|
9. |
Tali M, Maaroos J. Lower limbs function and pain relationships after unilateral total knee arthroplasty[J]. Int J Rehabil Res, 2010, 33(3):264-267.
|
10. |
Wheeler M, Oderda GM, Ashburn MA, et al. Adverse events associated with postoperative opioid analgesia:a systematic review[J]. J Pain, 2002, 3(3):159-180.
|
11. |
Brokelman RB, Van Loon CJ, Rijnberg WJ. Patient versus surgeon satisfaction after total hip arthroplasty[J]. J Bone Joint Surg Br, 2003, 85(4):495-498.
|
12. |
Deleo JA. Basic science of pain[J]. J Bone Joint Surg Am, 2006, 88A(2):58-62.
|